Certified by Founder Lodge
Kinnevik
Sweden - Stockholm, Stockholm
INVESTOR
1 Disclosed Funding Rounds $151,000,000
21 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Kinnevik’s ambition is to be Europe’s leading listed growth investor, and we back the best digital companies for a reimagined everyday and to deliver significant returns. We understand comple
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 06 ,2022 | Unknown | $151,000,000.00 |
| Company | Date | Round | Raised |
|---|---|---|---|
Lunar |
March, 10 ,2022 | Series D | $77,000,000 |
Oda |
December, 06 ,2022 | Unknown | $151,000,000 |
TravelPerk |
January, 12 ,2022 | Series D | $115,000,000 |
Mews |
December, 16 ,2022 | Series C | $185,000,000 |
Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
Gordian Software |
July, 19 ,2022 | Series A | $25,000,000 |
Budbee |
May, 23 ,2022 | Series C | $40,000,000 |
Charm Industrial |
June, 06 ,2023 | Series B | $100,000,000 |
SafetyWing |
April, 21 ,2022 | Series B | $35,000,000 |
Aira |
January, 17 ,2024 | Series B | $158,000,000 |
Lunar |
March, 10 ,2022 | Series D | $77,000,000 |
Spring Health |
August, 01 ,2024 | Series E | $100,000,000 |
TravelPerk |
January, 12 ,2022 | Series D | $115,000,000 |
Enveda |
November, 22 ,2024 | Series C | $130,000,000 |
Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
Tandem Health |
July, 01 ,2025 | Series A | $50,000,000 |
Charm Industrial |
June, 06 ,2023 | Series B | $100,000,000 |
Aira |
January, 17 ,2024 | Series B | $158,000,000 |
Spring Health |
August, 01 ,2024 | Series E | $100,000,000 |
Enveda |
November, 22 ,2024 | Series C | $130,000,000 |
Tandem Health |
July, 01 ,2025 | Series A | $50,000,000 |
Lunar
Oda
TravelPerk
Mews
Enveda Biosciences
Gordian Software
Budbee
Charm Industrial
SafetyWing
Aira
Spring Health
Enveda
Tandem Health
dezerv.
FalconX
Kristal.AI
Finary
Savart
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)